[Corrections] Correction to Lancet Oncol 2022; 23: 1308–20

Tree A C, Ostler P, van der Voet H, et al. Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial. Lancet Oncol 2022; 23: 1308–20—This Article should have been published under a CC BY Open Access license. This correction has been made to the online version as of May 2, 2023.